THERESE Study ((The influence of heart failure with preserved ejection fraction on 2-year mortality in patients with chronic obstructive pulmonary disease) – multicentric, prospective, case-control trial protocol).

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F20%3A73603366" target="_blank" >RIV/61989592:15110/20:73603366 - isvavai.cz</a>

Result on the web

<a href="http://www.pneumologie.cz/cislo/1747/4-2020/" target="_blank" >http://www.pneumologie.cz/cislo/1747/4-2020/</a>

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

THERESE Study ((The influence of heart failure with preserved ejection fraction on 2-year mortality in patients with chronic obstructive pulmonary disease) – multicentric, prospective, case-control trial protocol).

Original language description

Introduction: Heart failure with preserved ejection fraction (HFpEF) is highly prevalent among patients with chronic obstructive pulmonary disease (COPD). It could possibly negatively influence mortality of COPD patients but currently, robust data are missing. Aim: The aim of THERESE study (The influence of hearT failure with preserved ejection fraction on 2-year mortality of patients with cHronic obstructivE pulmonaRy disEaSE) is to assess the potential influence of HFpEF on mortality of COPD patients in stages C and D according to Global Initiative for Obstructive Lung Disease (GOLD) criteria. Methods: This is a multicentric, prospective case-control study where we are 150 patients. Discussion: The data from THERESE study will provide us with information about possible influence of HFpEF on mortality of patients with COPD. This could be important in the future management of COPD patients as the potentially immediate diagnosis of HFpEF and its subsequent treatment o fit could improve the patients prognosis. We will also have available data about the prevalence of HFpEF among different COPD phenotypes as this is the secondary endpoint of this study. Study Registration: ClinicalTrials.gov Identifier: NCT04277429

Czech name

—

Czech description

—

Type

J_SC - Article in a specialist periodical, which is included in the SCOPUS database

CEP classification

—

OECD FORD branch

30203 - Respiratory systems

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2020

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Studia Pneumologica et Phthiseologica

ISSN

1213-810X

e-ISSN

—

Volume of the periodical

80

Issue of the periodical within the volume

4

Country of publishing house

CZ - CZECH REPUBLIC

Number of pages

5

Pages from-to

170-174

UT code for WoS article

—

EID of the result in the Scopus database

999